{"schema_version":"secwatch.filing_event.v1","accession":"0001157523-23-001176","form_type":"8-K","ticker":"ACHC","cik":"0001520697","company_name":"Acadia Healthcare Company, Inc.","filed_at":"2023-07-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.181438+00:00","generated_at":"2026-06-13T00:24:42.309183+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Acadia Healthcare Q2 revenue up 12.2%; raises FY2023 guidance; acquires Turning Point Centers","bullets":["Revenue $731.3M, up 12.2% YoY; adjusted EPS $0.92 vs $0.79 GAAP.","Adjusted EBITDA $174.5M, up 10.9% YoY, excluding $8.6M CARES Act income.","Raised FY2023 guidance: revenue $2.86-2.90B, adjusted EPS $3.25-3.50, adj. EBITDA $655-685M.","Signed definitive agreement to acquire Turning Point Centers (76-bed specialty provider in Utah); expected close in 2023.","Added 98 beds to existing facilities in Q2, totaling 204 beds in H1 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001157523-23-001176","json":"https://secwatch.observer/filing/0001157523-23-001176.json","markdown":"https://secwatch.observer/filing/0001157523-23-001176.md","text":"https://secwatch.observer/filing/0001157523-23-001176.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1520697/000115752323001176/0001157523-23-001176-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1520697/000115752323001176/a53488939.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T00:24:42.309183+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f425592ef34a0306a7f72e8752972644b41988f1","claim":"Acadia Healthcare Company, Inc. reported the second quarter ended June 30, 2023 results: revenue $731.3 million, net income $72.3 million, EPS $0.79 per diluted share. Guidance raised.","evidence_excerpt":"Company, Inc. (“Acadia”) (NASDAQ: ACHC) today announced financial results for the second quarter ended June 30, 2023. Second Quarter and Recent Highlights Revenue totaled $731.3 million, an increase of 12.2% over the second quarter of 2022 Same facility revenue increased 11.4% compared with the second quarter of 2022, including an increase in revenue per patient","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1520697/000115752323001176/0001157523-23-001176-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the second quarter ended June 30, 2023"},{"label":"Revenue","value":"$731.3 million"},{"label":"Net income","value":"$72.3 million"},{"label":"EPS","value":"$0.79 per diluted share"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}